•    Big Lots, Inc. (NYSE:BIG) reported Q1 EPS of $0.70, above the Zacks Consensus Estimates of $0.68 per share. Revenues for the quarter fell 0.6% year-over-year to $1.23 billion, lower than the Zacks Consensus Estimate of $1.276 billion


•    TD Bank Group (NYSE:TD) announced Q2 EPS of $1.62, lower than the Zacks Consensus Estimate of $1.66 per share. Revenues for the quarter grew 7.5% year-over-year to $5.23 billion, falling short of the Zacks Consensus Estimate of $5.355 billion


•    Tiffany & Co. (NYSE:TIF) posted Q1 EPS of $0.63, higher than the Zacks Consensus Estimate of $0.57. Revenues for the quarter grew 20% year-over-year to $761 million, beating the Zacks Consensus Estimate of $701 million


•    H.J. Heinz Company (NYSE:HNZ) announced Q4 EPS of $0.69, lower than the Zacks Consensus Estimate of $0.72 per share. Revenues for the quarter grew 6% year-over-year to $2.89 billion, above the Zacks Consensus Estimate of $2.872 billion


•    Canaccord Genuity initiated coverage on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) with a "Buy" rating and set a target price of $6.00 on the stock

•    Ladenburg Thalmann initiated coverage on American Water Works Co., Inc. (NYSE:AWK) with a “Neutral” rating and a target price of $31.00


•    Global Hunter Securities initiated coverage on Trius Therapeutics Inc (NASDAQ:TSRX) with a “Buy” rating along with a target price of $11.00


•    Analysts at BMO Capital Markets downgraded Diamond Foods (NASDAQ:DMND) to "Market Perform" rating from an “Outperform” rating


•    JPMorgan Chase & Co. (NYSE:JPM) downgraded Gen-Probe Incorporated (NASDAQ:GPRO) to “Neutral” rating from “Overweight” rating with a target price of $85.00


•    Goldman Sachs (NYSE:GS) downgraded RadioShack (NYSE:RSH) to “Neutral” rating from “Buy” rating with a target price of $17.00


 
ACELRX PHARMACT (ACRX): Free Stock Analysis Report
 
AMER WATER WORK (AWK): Free Stock Analysis Report
 
BIG LOTS INC (BIG): Free Stock Analysis Report
 
DIAMOND FOODS (DMND): Free Stock Analysis Report
 
GEN-PROBE INC (GPRO): Free Stock Analysis Report
 
GOLDMAN SACHS (GS): Free Stock Analysis Report
 
HEINZ (HJ) CO (HNZ): Free Stock Analysis Report
 
JPMORGAN CHASE (JPM): Free Stock Analysis Report
 
RADIOSHACK CORP (RSH): Free Stock Analysis Report
 
TORONTO DOM BNK (TD): Free Stock Analysis Report
 
TIFFANY & CO (TIF): Free Stock Analysis Report
 
TRIUS THERAPEUT (TSRX): Free Stock Analysis Report
 
Zacks Investment Research
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more AcelRX Pharmaceuticals Charts.
AcelRX Pharmaceuticals (NASDAQ:ACRX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more AcelRX Pharmaceuticals Charts.